LIMITING DILUTION ANALYSIS OF CYTOTOXIC LYMPHOCYTES-T TO HUMAN-IMMUNODEFICIENCY-VIRUS GAG ANTIGENS IN INFECTED PERSONS - INVITRO QUANTITATION OF EFFECTOR CELL-POPULATIONS WITH P17 AND P24 SPECIFICITIES

被引:108
作者
KOUP, RA
PIKORA, CA
LUZURIAGA, K
BRETTLER, DB
DAY, ES
MAZZARA, GP
SULLIVAN, JL
机构
[1] UNIV MASSACHUSETTS,SCH MED,DEPT PEDIAT,PROGRAM MOLEC MED,WORCESTER,MA 01655
[2] THERION BIOL CORP,CAMBRIDGE,MA 02142
[3] UNIV MASSACHUSETTS,SCH MED,DEPT MED,WORCESTER,MA 01655
关键词
D O I
10.1084/jem.174.6.1593
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The presence of cytotoxic T lymphocytes (CTL) to the gag antigens of human immunodeficiency virus (HIV) has been described in infected populations. We found that the majority of this immune response as measured in bulk CTL assays of unstimulated peripheral blood mononuclear cells (PBMC) is directed against the p24 component of the p55 gag precursor protein. Using limiting dilution analysis of this effector cell population we confirm that the majority of activated gag-specific CTL circulating in the PBMC of infected hemophilic patients are directed at p24 determinants and are present at frequencies of 1/36,000 to 1/86,000 lymphocytes. By performing in vitro stimulation after limiting dilution, the precursor population of gag-specific CTL are characterized and quantitated. HIV gag-specific CTL precursors are identified at frequencies of 1/1700 to 1/17,000 lymphocytes and are made up of cells with both p17 and p24 specificities. No HIV gag-specific CTL precursor cells are identified in the PBMC of HIV-uninfected individuals. These studies demonstrate that CTL directed at both p17 and p24 determinants make up the cellular immune repertoire in HIV-infected individuals but that only the p24-specific CTL are routinely found in an activated state in the circulation.
引用
收藏
页码:1593 / 1600
页数:8
相关论文
共 30 条
  • [1] HGP-30, A SYNTHETIC ANALOG OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) P17, IS A TARGET FOR CYTOTOXIC LYMPHOCYTES IN HIV-INFECTED INDIVIDUALS
    ACHOUR, A
    PICARD, O
    ZAGURY, D
    SARIN, PS
    GALLO, RC
    NAYLOR, PH
    GOLDSTEIN, AL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 7045 - 7049
  • [2] BIDDISON WE, 1981, J IMMUNOL, V127, P487
  • [3] AIDS VACCINE PREDICTIONS
    COATES, ARM
    COOKSON, J
    BARTON, GJ
    ZVELEBIL, MJ
    STERNBERG, MJE
    [J]. NATURE, 1987, 326 (6113) : 549 - 550
  • [4] HIGH-FREQUENCY OF MEMORY AND EFFECTOR GAG SPECIFIC CYTOTOXIC LYMPHOCYTES-T IN HIV SEROPOSITIVE INDIVIDUALS
    GOTCH, FM
    NIXON, DF
    ALP, N
    MCMICHAEL, AJ
    BORYSIEWICZ, LK
    [J]. INTERNATIONAL IMMUNOLOGY, 1990, 2 (08) : 707 - 712
  • [5] HOFFENBACH A, 1989, J IMMUNOL, V142, P452
  • [6] JOHNSON RP, 1991, J IMMUNOL, V147, P1512
  • [7] GROUP-SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-RESTRICTED CYTO-TOXIC RESPONSES TO HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) ENVELOPE PROTEINS BY CLONED PERIPHERAL-BLOOD T-CELLS FROM AN HIV-1-INFECTED INDIVIDUAL
    KOENIG, S
    EARL, P
    POWELL, D
    PANTALEO, G
    MERLI, S
    MOSS, B
    FAUCI, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) : 8638 - 8642
  • [8] KOUP RA, 1989, BLOOD, V73, P1909
  • [9] ANTIGENIC SPECIFICITY OF ANTIBODY-DEPENDENT CELL-MEDIATED CYTO-TOXICITY DIRECTED AGAINST HUMAN IMMUNODEFICIENCY VIRUS IN ANTIBODY-POSITIVE SERA
    KOUP, RA
    SULLIVAN, JL
    LEVINE, PH
    BREWSTER, F
    MAHR, A
    MAZZARA, G
    MCKENZIE, S
    PANICALI, D
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (02) : 584 - 590
  • [10] EVIDENCE FOR 3 TYPES OF HUMAN CYTOTOXIC LYMPHOCYTE
    LANIER, LL
    PHILLIPS, JH
    [J]. IMMUNOLOGY TODAY, 1986, 7 (05): : 132 - 134